SEC Form 4 · accession 0001185185-15-003188
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristin C Comella
Officer — Chief Scientific Officer · Director
Period of report
Nov 2, 2015
Accepted (ET)
Dec 1, 2015 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.24 | Nov 2, 2015 | A | 5,000 | A | — | Nov 2, 2025 | Common Stock | 5,000 | 17,631 | D |
| Stock Options (right to buy) | $1.71 | Nov 2, 2015 | A | 175,131 | A | Nov 2, 2015 | Nov 2, 2025 | Common Stock | 175,131 | 192,762 | D |
Explanation of responses
- F11,250 vest on 11/02/2016, 1,250 vest on 11/02/2017, 1,250 vest on 11/02/2018, 1,250 vest on 11/02/2019.